1. Home
  2. AGEN vs IDN Comparison

AGEN vs IDN Comparison

Compare AGEN & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.93

Market Cap

178.2M

Sector

Health Care

ML Signal

HOLD

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$9.00

Market Cap

153.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
IDN
Founded
1994
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
178.2M
153.8M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
AGEN
IDN
Price
$3.93
$9.00
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$14.50
$7.33
AVG Volume (30 Days)
1.0M
508.2K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
220.00
EPS
N/A
0.06
Revenue
$42,877,086.00
$4,433,454.00
Revenue This Year
$107.63
$12.54
Revenue Next Year
N/A
$15.32
P/E Ratio
$8.89
$144.67
Revenue Growth
89.95
23.21
52 Week Low
$2.63
$2.47
52 Week High
$7.34
$8.90

Technical Indicators

Market Signals
Indicator
AGEN
IDN
Relative Strength Index (RSI) 49.56 77.75
Support Level $2.96 $4.50
Resistance Level $4.58 N/A
Average True Range (ATR) 0.42 0.50
MACD -0.03 0.06
Stochastic Oscillator 37.53 95.87

Price Performance

Historical Comparison
AGEN
IDN

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: